Showing results (451-460 of 512) with videos related to

Sort By:
Pageof 52
BMJ Open Gastroenterology|January 8, 2025
Cardiovascular events observed among patients in the etrasimod clinical programme: an integrated safety analysis of patients with moderately to severely active ulcerative colitisSéverine Vermeire, David T Rubin, Laurent Peyrin-Biroulet, et al.
Gastroenterology|October 6, 2019
Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized TrialSelina R Cox, James O Lindsay, Sébastien Fromentin, et al.
Digestive Diseases and Sciences|January 10, 2022
Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness MethodologyGaurav Syal, Miles P Sparrow, Fernando Velayos, et al.
Nature Immunology|November 14, 2018
The γδTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsivenessDaisy Melandri, Iva Zlatareva, Raphaël A G Chaleil, et al.
Journal of the American Chemical Society|October 11, 2023
Interfacial Bonding between a Crystalline Metal-Organic Framework and an Inorganic GlassCelia Castillo-Blas, Ashleigh M Chester, Ronan P Cosquer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 11, 2010
The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit allGil Y Melmed, Brennan M Spiegel, Brian Bressler, et al.
Journal of Crohn'S & Colitis|June 13, 2021
A Crohn's Disease-associated IL2RA Enhancer Variant Determines the Balance of T Cell Immunity by Regulating Responsiveness to IL-2 SignallingRimma Goldberg, Jennie N Clough, Luke B Roberts, et al.
Inflammatory Bowel Diseases|April 9, 2016
Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness PanelShane M Devlin, Gil Y Melmed, Peter M Irving, et al.
Chemical Science|November 3, 2023
Structural insights into hybrid immiscible blends of metal-organic framework and sodium ultraphosphate glassesAshleigh M Chester, Celia Castillo-Blas, Roman Sajzew, et al.
Contemporary Clinical Trials Communications|December 17, 2025
Design and rationale for the VICTRIVA study: A randomized, double-blind, phase 3b study of vedolizumab in combination with upadacitinib in Crohn's diseaseSilvio Danese, Bruce E Sands, Brian G Feagan, et al.
Pageof 52